Representative before the EPO

Employment test 201 - 500 employees
Company dna awapatent
operating since 1897
1162.29
Headquarter in Malmö and 14 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Inga-Lill Andersson has worked on the following 15 EPO patent applications which have been published in the last five years:

EP11823854

FIXATION DEVICE

IPC classification:
A61F 13/02, A61M 25/02
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Agent:
Maria Börlin, Zacco Sweden AB
Status:
GRANT OF PATENT INTENDED
EP11181961

Polymer fibers

IPC classification:
A61L 15/22, A61L 15/26, D01D 5/08, D01F 1/10, D01F 6/70, D01F 6/94
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Agent:
Maria Börlin, Zacco Sweden AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12164095

Organic Field-Effect Transistor Device

IPC classification:
H01L 51/05
Applicant:
Acreo Swedish ICT AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12814751

METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANGIOGENIC AGENT

IPC classification:
A61K 38/17, A61K 39/395, A61P 25/28, C07K 14/47
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION IN PROGRESS
EP12769059

POLYMER FIBRE

IPC classification:
A61L 15/22, A61L 15/26, D01D 5/08, D01F 1/10, D01F 6/70, D01F 6/94
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
GRANT OF PATENT INTENDED
EP13701040

TETRAHYDROFOLATES IN COMBINATION WITH EGFR-INHIBITORS

IPC classification:
A61K 31/519, A61K 39/395, A61K 45/06, A61P 35/00
Applicant:
Isofol Medical AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION IN PROGRESS
EP13700418

ANTI-TUMOR ACTIVITY OF REDUCED FOLATES LIKE METHYLENE-TETRAHYDROFOLATE

IPC classification:
A61K 31/519, A61P 35/00
Applicant:
Isofol Medical AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12199049

Silicone film

IPC classification:
A61L 24/04
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
PATENT GRANTED
EP12717851

BIOSENSOR HAVING NANOSTRUCURED ELECTRODES

IPC classification:
B82Y 15/00, B82Y 30/00
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
GRANT OF PATENT INTENDED
EP13775009

METHODS FOR BLADDER CANCER THERAPY USING BACULOVIRAL VECTORS

IPC classification:
A61K 31/7088, A61K 35/76, A61P 35/00, C12N 15/86
Applicant:
Agency for Science, Technology and Research
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION IN PROGRESS
EP13737672

SUBSTITUTED HETERO-BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF

IPC classification:
A61K 31/519, A61P 19/02, C07D 403/14, C07D 413/14
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
PATENT GRANTED
EP13819944

IN VITRO ASSAY FOR PREDICTING RENAL PROXIMAL TUBULAR CELL TOXICITY

IPC classification:
C12Q 1/06, G01N 33/483, G01N 33/533
Applicant:
Agency for Science, Technology and Research
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
The patent has been granted
EP13811956

SILICONE FILM

IPC classification:
A61L 24/04
Applicant:
Mölnlycke Health Care AB
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
GRANT OF PATENT INTENDED
EP14745832

BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE WITH ANKYLOSING SPONDYLITIS

IPC classification:
G01N 33/564
Applicant:
University Health Network (UHN)
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14745446

J-AGGREGATE FORMING NANOPARTICLE

IPC classification:
A61K 47/22, A61K 47/24, A61K 49/00, A61K 49/22
Applicant:
University Health Network (UHN)
Agent:
Inga-Lill Andersson, Awapatent AB
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature